For Immediate Release
Uncommon Cures, LLC is pleased to announce that Dr. Tam Roshan Lal has joined the company as Chief Medical Officer. Dr. Roshan Lal is an experienced rare disease clinician with extensive clinical trials experience. Prior to joining Uncommon Cure, she worked as an Attending Metabolic Geneticist at the Rare Disease Institute (RDI), Childrens National Hospital. During her time at the RDI, she was the Director of Clinical Trials, Director of International Patient Consultation and Care Referrals, as well as Director of the Genomic Therapeutic Clinics. She completed her medical education at University of Manchester, UK. She went on to train in multiple specialties which include Pediatrics, Obstetrics & Gynecology, General Medicine, General Surgery, as well as Critical Care. Dr. Roshan Lal completed a Pediatric Residency at Sinai Hospital, Baltimore and went on to do a Genetics fellowship at Johns Hopkins. She concurrently did research on lysosomal storage diseases at the National Institutes of Health (NIH). She served as the Chief Resident of the Genetics department at Johns Hopkins prior to completing a fellowship in Medical Biochemical Genetics at the same institution. She has received numerous awards for both her clinical care and research. She is currently an MBA candidate at the Alliance Manchester Business School, UK. Dr. Roshan Lal has been a principal investigator for multiple rare disease clinical trials and developed numerous protocols for rare disease drug development studies. She has written many peer-reviewed publications as well as book chapters on rare diseases and their management. Uncommon Cures is excited about what she brings to the team as our Chief Medical Officer.
